Fibrocell Science, Inc. Forms 3, 4 and 5: Stock Options
Statements of beneficial ownership filed with the SEC by officers, directors and 10% owners: 13 rows in 2013. Transaction codes are the SEC's. Shares and prices are split-adjusted; the as-filed figure is underneath.
- 2013-11-15: Reporting owner Pernock David; Form 4; Security Option to Purchase Common Stock; Transaction A Grant, award or other acquisition pursuant to Rule 16b-3(d).
- 2013-08-26: Reporting owner WEAVER GREGORY L; Form 4; Security Option to purchase common stock; Transaction A Grant, award or other acquisition pursuant to Rule 16b-3(d).
- 2013-07-19: Reporting owner Mazur Marc; Form 4; Security Option to Purchase Common Stock; Transaction A Grant, award or other acquisition pursuant to Rule 16b-3(d).
- 2013-07-19: Reporting owner Moore Kelvin; Form 4; Security Option to Purchase Common Stock; Transaction A Grant, award or other acquisition pursuant to Rule 16b-3(d).
| Transaction date | Reporting owner | Form | Security | Transaction | Shares | Price | Price that day | Filing |
|---|---|---|---|---|---|---|---|---|
| 2013-11-15 | Pernock David Director, Officer (Chief Executive Officer) | 4 | Option to Purchase Common Stock Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +800,000 1,203,000 owned after | $3.40 exercise price | 2013-11-18 | |
| 2013-08-26 | WEAVER GREGORY L Officer (Chief Financial Officer) | 4 | Option to purchase common stock Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +125,000 125,000 owned after | $4.86 exercise price | 2013-08-28 | |
| 2013-07-19 | Mazur Marc Director | 4 | Option to Purchase Common Stock Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +24,000 52,000 owned after | $5.49 exercise price | 2013-07-23 | |
| 2013-07-19 | Moore Kelvin Director | 4 | Option to Purchase Common Stock Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +24,000 48,000 owned after | $5.49 exercise price | 2013-07-23 | |
| 2013-07-19 | St.Clare Christine Director | 4 | Option to Purchase Common Stock Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +24,000 32,000 owned after | $5.49 exercise price | 2013-07-23 | |
| 2013-07-19 | Pernock David Director, Officer (Chief Executive Officer) | 4 | Option to Purchase Common Stock Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +175,000 403,000 owned after | $5.49 exercise price | 2013-07-23 | |
| 2013-07-19 | Swirsky Douglas J Director | 4 | Option to Purchase Common Stock Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +24,000 32,000 owned after | $5.49 exercise price | 2013-07-23 | |
| 2013-07-19 | Smith Marcus E. Director | 4 | Option to Purchase Common Stock Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +24,000 24,000 owned after | $5.49 exercise price | 2013-07-23 | |
| 2013-07-19 | Kirk Julian P. Director | 4 | Option to Purchase Common Stock Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +24,000 24,000 owned after | $5.49 exercise price | 2013-07-23 | |
| 2013-03-04 | Swirsky Douglas J Director | 4 | Option to purchase common stock Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +200,000 200,000 owned after | $0.15 exercise price | 2013-03-05 | |
| 2013-02-21 | Mazur Marc Director | 4 | Option to purchase common stock Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +200,000 700,000 owned after | $0.14 exercise price | 2013-02-25 | |
| 2013-02-21 | Moore Kelvin Director | 4 | Option to purchase common stock Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +200,000 600,000 owned after | $0.14 exercise price | 2013-02-25 | |
| 2013-02-21 | St.Clare Christine Director | 4 | Option to Purchase Common Stock Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +200,000 200,000 owned after | $0.14 exercise price | 2013-02-25 |